Literature DB >> 2939487

Diurnal rhythm of plasma beta endorphin, cortisol and growth hormone in schizophrenics as compared to control subjects.

I Gil-Ad, Z Dickerman, S Amdursky, Z Laron.   

Abstract

The diurnal variation of plasma beta endorphin was studied in ten schizophrenics, and in age/sex matched control subjects. In the controls beta endorphin was high in the morning (21.0 +/- 3.5 pmol/l) and decreased towards evening. In the schizophrenic group the beta endorphin fluctuated randomly, ranging within 9-40 pmol/l throughout the day. Plasma cortisol showed a normal diurnal pattern in both groups. The mean plasma cortisol levels in the schizophrenics were significantly higher than in the controls throughout the day. The pattern of plasma human growth hormone (hGH) level was similar in both groups at the time tested. It is hypothesized that the instability of beta endorphin secretion may contribute to the pathogenesis of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2939487     DOI: 10.1007/bf00178514

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  15 in total

1.  Endocrine changes in psychiatric diseases.

Authors:  P H Gruen
Journal:  Med Clin North Am       Date:  1978-03       Impact factor: 5.456

2.  beta-endorphin, blood-brain barrier, and schizophrenia.

Authors:  Y F Jacquet
Journal:  Lancet       Date:  1980-04-12       Impact factor: 79.321

3.  C.S.F. beta-endorphin in schizophrenia.

Authors:  W Domschke; A Dickschas; P Mitznegg
Journal:  Lancet       Date:  1979-05-12       Impact factor: 79.321

Review 4.  Endorphins in schizophrenia.

Authors:  J M van Ree; D De Wied
Journal:  Neuropharmacology       Date:  1981-12       Impact factor: 5.250

5.  Entry of opioid peptides into the central nervous system.

Authors:  S I Rapoport; W A Klee; K D Pettigrew; K Ohno
Journal:  Science       Date:  1980-01-04       Impact factor: 47.728

6.  Increased CSF levels of endorphines in chronic psychosis.

Authors:  L Terenius; A Wahlström; L Lindström; E Widerlöv
Journal:  Neurosci Lett       Date:  1976-10       Impact factor: 3.046

7.  beta-Endorphin and adrenocorticotropin are selected concomitantly by the pituitary gland.

Authors:  R Guillemin; T Vargo; J Rossier; S Minick; N Ling; C Rivier; W Vale; F Bloom
Journal:  Science       Date:  1977-09-30       Impact factor: 47.728

8.  Diurnal rhythm of beta endorphin in normotensive and hypertensive patients: the effect of clonidine.

Authors:  C Farsang; L Vajda; J Kapocsi; Z Malisák; S Alföldi; K Varga; I Juhász; G Kunos
Journal:  J Clin Endocrinol Metab       Date:  1983-04       Impact factor: 5.958

9.  Diurnal rhythm of plasma immunoreactive beta-endorphin and its relationship to sleep stages and plasma rhythms of cortisol and prolactin.

Authors:  R R Dent; C Guilleminault; L H Albert; B I Posner; B M Cox; A Goldstein
Journal:  J Clin Endocrinol Metab       Date:  1981-05       Impact factor: 5.958

10.  Use of naloxone in schizophrenic psychoses and manic syndromes.

Authors:  W M Verhoeven; H M van Praag; J T de Jong
Journal:  Neuropsychobiology       Date:  1981       Impact factor: 2.328

View more
  5 in total

1.  Pain sensitivity is altered in animals after subchronic ketamine treatment.

Authors:  Axel Becker; Gisela Grecksch; Helmut Schröder
Journal:  Psychopharmacology (Berl)       Date:  2006-10-03       Impact factor: 4.530

2.  A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism.

Authors:  H Y Chan; C J Chang; S C Chiang; J J Chen; C H Chen; H J Sun; H G Hwu; M S Lai
Journal:  J Psychopharmacol       Date:  2008-09-18       Impact factor: 4.153

3.  The relationship between cortisol reactivity and emotional brain function is differently moderated by childhood trauma, in bipolar disorder, schizophrenia and healthy individuals.

Authors:  Yann Quidé; Leah Girshkin; Oliver J Watkeys; Vaughan J Carr; Melissa J Green
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-09-14       Impact factor: 5.270

4.  Are cardiometabolic and endocrine abnormalities linked to sleep difficulties in schizophrenia? A hypothesis driven review.

Authors:  Rébecca Robillard; Naomi L Rogers; Bradley G Whitwell; Tim Lambert
Journal:  Clin Psychopharmacol Neurosci       Date:  2012-04-30       Impact factor: 2.582

5.  Comparison of beta-endorphin and CGRP levels before and after treatment for severe schizophrenia.

Authors:  Małgorzata Urban-Kowalczyk; Janusz Śmigielski; Dominik Strzelecki
Journal:  Neuropsychiatr Dis Treat       Date:  2016-04-15       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.